Skip to main content

Table 2 Demographic characteristics and common CVD risk factors of the participants

From: Cardiovascular autonomic neuropathy in people with type 2 diabetes mellitus; investigation of its association with classical cardiovascular risk factors using cardiovascular autonomic reflex tests: a cross-sectional study

Variable N=26 type 2 DM
Age (years) 60.8 ± 10.4
Sex, F (%) 38.5%
Height (m) 1.7 ± .10
Weight (kg) 92.4 ± 23
BMI (kg/m2) 30.8 (29.1–36.7)
Body fats % 33.9 ± 6.8
Heart rate rest (bpm) 71.4 ± 12.1
Resting SBP (mmHg) 132 ± 15.7
Resting DBP (mmHg) 80 ± 9.9
Total cholesterol (mmol/L) 4.6 ± .96
Triglycerides (mmol/L) 1.4 ± .56
HDL (mmol/L) 1.2 ± .22
LDL (mmol/L) 2.8 ± .93
HOMA 2.3 (1.5–4.5)
Ewing’s score 2 (1.25–2.5)
VO2peak (ml/kg/min) 22.3 ± 4.5
Medications
 Statins (%) 46.2%
 Biguanides (%) 53.8%
 ACE inhibitors (%) 34.6%
 Ca channel blockers (%) 7.7%
 Diuretics (%) 7.7%
 Gliclazide (%) 7.7%
 Fluoxetine (%) 7.7%
 Alpha-blockers (%) 3.8%
 Thyroxin (%) 3.8%
 Rivaroxaban (%) 3.8%
 Sitagliptin (%) 3.8%
 NSAIDs (%) 3.8%
 Beta-blockers (%) 3.8%
  1. Values are presented as means ± standard deviation or median (25th to 75th percentile values) as appropriate
  2. BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, HDL high-density lipoprotein, LDL low-density lipoprotein, HOMA homeostasis model assessment insulin resistance, Ewing’s score total score of the cardiovascular autonomic reflex tests, VO2peak the highest volume of oxygen, ACE angiotensin-converting enzyme, Ca calcium, NSAIDs non-steroidal anti-inflammatory drugs